Renaissance Technologies - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,176
-65.9%
925,919
-11.6%
0.00%
-60.0%
Q2 2023$3,448
-32.9%
1,047,919
-16.2%
0.01%
-28.6%
Q1 2023$5,140
+53.4%
1,250,519
+118.7%
0.01%
+40.0%
Q4 2022$3,350
-99.9%
571,719
-18.2%
0.01%
-28.6%
Q3 2022$4,724,000
+79.3%
698,819
+22.5%
0.01%
+133.3%
Q2 2022$2,635,000
-28.2%
570,319
-38.0%
0.00%
-25.0%
Q1 2022$3,668,000
+72.1%
919,200
+168.3%
0.00%
+33.3%
Q4 2021$2,131,000
+60.1%
342,600
+379.2%
0.00%
+200.0%
Q3 2020$1,331,000
-83.3%
71,500
-79.0%
0.00%
-85.7%
Q2 2020$7,962,000
+74.3%
340,268
-56.6%
0.01%
+75.0%
Q1 2020$4,568,000
+10.8%
783,568
+8.9%
0.00%
+33.3%
Q4 2019$4,124,000
+240.5%
719,768
-6.1%
0.00%
+200.0%
Q3 2019$1,211,000
+12.4%
766,725
+188.2%
0.00%0.0%
Q2 2019$1,077,000
+17.3%
266,020
+52.4%
0.00%0.0%
Q1 2019$918,000174,5200.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders